Genome Compiler welcomes Addgene in Providing a Better Way to Share and Design Plasmids

Los Altos, CA and Cambridge, MA -- Genome Compiler Corp., a Los Altos based synthetic biology software company entered into a collaborative agreement with Addgene, a non-profit organization dedicated to sharing plasmids, located in Cambridge, MA. Genome Compiler will be integrating Addgene repository of plasmids into its advanced design tools and marketplace platform, enabling users [...]

Appistry Extends Its Tools and Services for Analyzing Next-Generation Sequencing Data

ST LOUIS, MO -– Appistry, Inc., a leading provider of tools, software, and services that enable healthcare institutions to practice genomically enhanced medicine, today announced extensions to its next-generation sequencing (NGS) data analysis tools. An expanded set of analysis tools and pipelines is now available from Appistry through a new software application, GenomePilot. GenomePilot addresses [...]

Automation Compatible Ultra Low Temperature Tube Storage Racks

Precision manufactured in a certified Class 7 clean room production facility, the new 24-, 48- and 96-tube Ultra-Low Temperature (ULT) rack range from Micronic are based on the automation compatible ANSI / SLAS dimensional footprint. Micronic ULT racks incorporate a wealth of useful features to aid automation. These features include a novel Twist-Lock design which [...]

QIAGEN announces proposal for re-election of all current Supervisory Board members at next Annual General Meeting

VENLO, The Netherlands -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that all current members of the Supervisory Board will stand for re-election for the standard one-year term at the next Annual General Meeting on June 23, 2015. In addition, Dr. Werner Brandt, the Chairman of the Supervisory Board, has decided to [...]

Board Change – Halma plc

Halma, the leading safety, health and environmental technology group, announces today that Neil Quinn, who has been a Board member since 1998, will retire from the Company on 31 March 2016. Therefore, Neil will not be seeking re-election as a Director of the Company at the AGM on 23 July 2015 and will stand down [...]

Eurofins Bioanalytical Services introduces GLP-compliant Singulex® Erenna® Immunoassay services

St Charles, MO -- Eurofins Bioanalytical Services, a leading provider of bioanalytical testing to the biopharmaceutical industry, today announced introduction of services on the Singulex Erenna Immunoassay platform. The system is the latest high-tech addition to the laboratory that focuses on the Bioanalysis of large molecule therapeutics. Biopharmaceutical companies face ever more demanding technical challenges [...]

AMETEK INCREASES SHARE REPURCHASE AUTHORIZATION

BERWYN, Pa. -- AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has increased the authorized level for repurchases of its common stock by $350 million. This increased authorization will be added to the approximately $20 million that currently remains available from an existing authorization approved by the Board of Directors in November [...]

SGI-DNA Launches the BioXp™ 3200 System Early Access Program

LA JOLLA, CA -– SGI-DNA Inc. today announced the launch of the BioXp™ 3200 System Early Access Program giving researchers priority access to this one of a kind, personal DNA work station which delivers high quality synthetic DNA fragments. The BioXp™ Instrument has the capacity to simultaneously build 32 unique double-stranded DNA fragments. It is [...]

Biosearch and Co-Diagnostics Sign Cooperative Primers Agreement

Salt Lake City, UT -- Biosearch Technologies and Co-Diagnostics announced today an agreement allowing Biosearch to make, use, market and sell Co-Diagnostics’ CoPrimers™ technology to research institutions. The agreement also licenses CoPrimers™ technology to Biosearch for its own research and development. CoPrimers’™ unique patent-pending design greatly reduces the occurrence of primer-dimers, without the addition of [...]

OGT signs license with Wellcome Trust Sanger Institute

Oxford Gene Technology (OGT), the molecular genetics company, today announced that it has signed a license agreement with the Wellcome Trust Sanger Institute for access to data from the Deciphering Developmental Disorders (DDD) study. The DDD study has successfully identified new areas of the genome as responsible for developmental disorders1, 2. OGT plans to use [...]

Access IBO on Knowledge Center